Title:
７−アザインドリン−２−オン誘導体又はその薬学的に許容される塩を有効成分として含有する医薬組成物
Document Type and Number:
Japanese Patent JP6661766
Kind Code:
B2
Abstract:
The present invention relates to a 7-azaindolin-2-one derivative or a pharmaceutically acceptable salt thereof, and the 7-azaindolin-2-one derivative or the pharmaceutically acceptable salt thereof can be favorably used as a medicinal material for inhibiting cancer growth and cancer metastasis.
Inventors:
Byung-Sung Jung
Chun-Dae Kim
Tae Gu Nam
Chun-Dae Kim
Tae Gu Nam
Application Number:
JP2018524367A
Publication Date:
March 11, 2020
Filing Date:
October 31, 2016
Export Citation:
Assignee:
LG HAUSYS,LTD.
International Classes:
C07D471/04; A61K31/437; A61K31/444; A61K31/4545; A61K31/4709; A61K31/496; A61K31/5377; A61P35/00; A61P35/04
Domestic Patent References:
| JP2002522452A |
Foreign References:
| WO1999021859A1 | ||||
| WO2014160401A1 |
Other References:
Organic & Biomolecular Chemistry ,2014年,12(43),p.8702-8710
European Journal of Medicinal Chemistry,2014年,78,p.126-139
Organic & Biomolecular Chemistry,2016年,14(21),p.4829-4841
European Journal of Medicinal Chemistry,2014年,78,p.126-139
Organic & Biomolecular Chemistry,2016年,14(21),p.4829-4841
Attorney, Agent or Firm:
Shinya Mitsuhiro
Takashi Watanabe
Takashi Watanabe